Lycia Therapeutics, Inc. (LYCA) stock
LYCANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$31.35+0.43 (+1.39%)
Close on Nov 18, 2026Market cap –P/E –Yield –
Price history
Lycia Therapeutics share prices for every trading day, newest first. Adjusted for stock splits, not for dividends.
Close, Nov 18, 2026
$31.35
+1.39% on the day
52-week range
$22.19 – $36.49
-14.1% from the high
Change over 52 weeks
+4.5%
From $30.00 on Oct 23, 2026
Average volume
441,424
Shares a day, last 90 sessions
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Nov 18, 2026 | $30.60 | $32.85 | $30.45 | $31.35 | +1.39% | 383,617 |
| Nov 17, 2026 | $28.62 | $31.78 | $28.62 | $30.92 | +8.07% | 496,270 |
| Nov 16, 2026 | $31.04 | $32.40 | $28.18 | $28.61 | -8.30% | 250,880 |
| Nov 13, 2026 | $32.83 | $33.00 | $31.20 | $31.20 | -4.96% | 189,541 |
| Nov 12, 2026 | $32.00 | $33.44 | $30.90 | $32.83 | +4.42% | 496,081 |
| Nov 11, 2026 | $31.50 | $33.56 | $31.01 | $31.44 | +0.45% | 329,587 |
| Nov 10, 2026 | $30.36 | $31.57 | $29.84 | $31.30 | +3.10% | 239,519 |
| Nov 9, 2026 | $30.18 | $30.68 | $28.77 | $30.36 | -0.46% | 184,457 |
| Nov 6, 2026 | $28.91 | $31.18 | $28.91 | $30.50 | +5.90% | 370,060 |
| Nov 5, 2026 | $29.16 | $29.34 | $27.94 | $28.80 | -0.41% | 189,795 |
| Nov 4, 2026 | $27.48 | $28.92 | $26.42 | $28.92 | +4.78% | 302,654 |
| Nov 3, 2026 | $26.70 | $28.03 | $26.70 | $27.60 | +1.55% | 195,319 |
| Nov 2, 2026 | $27.14 | $27.66 | $26.01 | $27.18 | +2.95% | 270,782 |
| Oct 30, 2026 | $27.17 | $27.59 | $25.66 | $26.40 | -4.80% | 202,451 |
| Oct 29, 2026 | $25.25 | $27.83 | $24.51 | $27.73 | +10.70% | 173,148 |
| Oct 28, 2026 | $26.48 | $26.48 | $24.03 | $25.05 | -4.06% | 433,128 |
| Oct 27, 2026 | $26.51 | $28.00 | $24.63 | $26.11 | -9.50% | 426,848 |
| Oct 26, 2026 | $23.73 | $30.91 | $23.73 | $28.85 | -3.83% | 965,723 |
| Oct 23, 2026 | $28.55 | $36.49 | $22.19 | $30.00 | – | 2,287,202 |
See a number that looks wrong?